구강 편평상피세포암 동위종양 모델에서 내피세포의 수용체 타이로신 인산화효소에 대한 표적치료

키워드

참고문헌 (26)

1. Kupferman ME, "Molecular biology of oral cavity squamous cell carcinoma", Otolaryngol Clin North Am, 39(2), pp.229~247 (2006)
2. Choi S, "Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy", J Dent Res, 87(1), pp.14~32 (2008)
3. Maekawa T, "The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias", Int J Clin Oncol, 12(5), pp.327~340 (2007)
4. Traxler P, "AEE788 : A dual family epidermal growth factor receptor", ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity, 2004, pp.64, 4931~4941
5. Lopez-Albaitero A, "Immune activation by epidermal growth factor receptor-specific monoclonal antibody therapy for head and neck cancer", Arch Otolaryngol Head Neck Surg, 133(12), pp.1277~1281 (2007)
6. 박영욱, "구강 편평상피세포암 동위종양 모델에서 전이관련 인자의 발현", 대한악안면성형재건외과학회지, 30(6), pp.529~539 (2008), 대한악안면성형재건외과학회
7. Park YW, "AEE788, a dual tyrosine kinase inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice", Clin Cancer Res, 11, pp.1963~1973 (2005)
8. Yigitbasi OG, "Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade", Cancer Res, 64, pp.7977~7984 (2004)
9. Younes MN, "Hawthorne VS et al : Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation", Cancer Res, 65, pp.4716~4727 (2005)
10. Schiff BA, "Epidermal frowth factor receptor(EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer", Clin cancer res, 10(24), pp.8594~8602 (2004)
11. Kuwai T, "Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors", Neoplasia, 10(5), pp.489~500 (2008)
12. Sano D, "Metastasis of squamous cell carcinoma of the oral tongue", Cancer Metastasis Rev, 26, pp.645~662 (2007)
13. 박영욱, "구강 편평상피세포암 마우스 모델에서 상피성장인자 수용체 억제제를 적용한 분자표적치료", 대한악안면성형재건외과학회지, 31(1), pp.8~17 (2009), 대한악안면성형재건외과학회
14. Yazici S, "Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice", Prostate, 65(3), pp.203~215 (2005)
15. Yokoi K, "Induction of apoptosis on tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice", Neoplasia, 7(7), pp.696~704 (2005)
16. Yu C, "Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation", Clin cancer res, 13(4), pp.1140~1148 (2007)
17. Sasaki T, "Inhibition if epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice", Neoplasia, 9(12), pp.1066~1077 (2007)
18. Magkou C, "Expression of the epidermal growth factor receptor(EGFR) and the phosphorylated EGFR in invasive breast carcinomas", Breast cnacer research, 10(3), pp.1~8 (2008)
19. Verheul HMW, "Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model", Clin cancer res, 13(14), pp.4201~4208 (2007)
20. Roberts N, "Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2", Cancer res, 66(5), pp.2650~2657 (2006)
21. Laakkonen P, "Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth", Cancer res, 67(2), pp.593~599 (2007)
22. He Y, "Vascular endothelial growth factor receptor 3- mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels", Cancer Res, 65(11), pp.4739~4746 (2005)
23. Dumont DJ, "Cardiovascular failure in mouse embryos deficient in VEGF receptor-3", Science, 282, pp.946~949 (1998)
24. Yokoi K, "Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model", Cancer res, 65(9), pp.3716~3725 (2005)
25. Rebhun RB, "Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis", Neoplasia, 8(9), pp.747~757 (2006)
26. Wang D, "Immunohistochimistry for the evaluation of angiogenesis in tumor xenografts", Biotech Histochem, 83(3), pp.179~189 (2008)

관련 논문AI추천